Sat, Sep 20, 2014, 9:45 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • vskomarovsky vskomarovsky Nov 4, 2012 11:24 AM Flag

    from Forbes

    There have been changes to the FDA. One of the most dramatic, as a result of a recently passed law, is that many more medicines should be approved on an “accelerated” basis, before results are in. Wall Street has woken up to this. Extremely positive results for a muscular dystrophy drug developed by Sarepta Therapeutics are being talked about as a reason the medicine might be approved.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
21.78-0.75(-3.33%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.